Skip to content

Clinical trials

Completed Purpura, Thrombocytopenic, Idiopathic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Status: Completed Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20081
20092
20122
20131
20144
20181
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
GlaxoSmithKline2
Principia Biopharma, a Sanofi Company2
Rigel Pharmaceuticals2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Boston Children's Hospital1
Bristol-Myers Squibb1
Grifols Biologicals, LLC1
Hamilton Health Sciences Corporation1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic17
Thrombocytopenia8
Purpura4
Hemorrhage2
Purpura, Thrombocytopenic2
Anemia, Hemolytic1
Anemia, Hemolytic, Autoimmune1
Autoimmune Diseases1
Blood Coagulation Disorders1
Blood Platelet Disorders1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.